We're no longer posting updates here. Get the latest news on LinkedIn, our blog (https://xitter.cf/t.co/6qLM8LXZ0D) or sign up for alerts (https://xitter.cf/t.co/5Qu72ej6WQ).
BOS & SFO
Joined February 2012
- Tweets506
- Following159
- Followers3.6K
- Likes369
Pinned Tweet
New pivotal trial data on EndeavorRx in adolescents ages 13-17 with ADHD released this morning. See topline results here in our release issued this morning: investors.akiliinteractive.c…
We're no longer posting updates on Twitter. For the latest Akili news, please check out our blog, visit us on LinkedIn or sign up to have Akili news delivered to your inbox: bit.ly/akilialerts
Akili leaders will speak at @Cowen_Inc 43rd Annual Health Care conference on March 8. investors.akiliinteractive.c…
We loved talking about the #science behind #adhd with @SCFG! Learn more about how your brain gives you superpowers: youtube.com/watch?app=deskto…
We’re taking you behind the scenes of the work we’re doing to advance the field of #cognitivescience. Read more in our blog post: akiliinteractive.com/console…
Kids deserve better. Our new Chief Medical Officer, @skollins1, writes about the need to challenge the status quo within #ADHD care management. Read more: akiliinteractive.com/console…
We'll discuss the relationship between objective measures of attention and academic performance in children with ADHD at #PsychUpdateWinter22
We're thrilled to announce that @skollins1 has joined Akili as Chief Medical Officer. His experience with innovative approaches to ADHD treatment will be invaluable as we work to deliver for patients and their families every day. tinyurl.com/5e5vmp59
ALT "We have treated ADHD in the U.S. in virtually the same way for more than 50 years. Providers and patients need new options.” -- Scott Kollins, Ph.D., Chief Medical Officer, Akili Adjunct Professor, Department of Psychiatry and Behavioral Science, Duke University School of Medicine
Our COO recently spoke with @MassDevice podcast, @DeviceTalks, about his career and work to scale our flagship product. Listen here: devicetalks.com/akili-looks-…
We're wrapping up the last day of @CHADD_ADHD #ADHD2022 at Booth 102 and the Relaxicus Retreat. Come check out an interactive demo and learn more!
"The status of our ADHD care management is unacceptable, and it has been for a very long time...Our innovation in treatment and diagnosis has stagnated for years. We need something new; something different." - @skollins1 at #ADHD2022 @CHADD_ADHD
We're in Dallas today kicking off @CHADD_ADHD's Annual International Conference. Members of our team will be hosting focus groups, roundtables, and giving hands-on demos of our flagship product at Booth 102.
We’re honored to receive the @ucsfhealthhub’s Digital Health Awards Best in Class Award in the Mental and Behavioral Health category.
A mental health emergency impacting our nation’s youth was declared a year ago, and patients need new, non-drug treatment options.
ALT Gold shield with text: UCSF Health Hub Digital Health Awards 2022 Best in Class Winner: Mental and Behavioral Health Akili
We're at #OMTechnology today, speaking about harnessing the power of digital therapeutics (#DTx) in pediatrics. We'll see you there at 9:15am PT! @openmindscircle
Winning the #PrixGalien Startup Award represents how far we’ve come in changing the world’s perception of medicine. But there is still work to do to solve the cognitive issues that are one of this decade’s biggest unmet needs.
We’re committed to continuing to challenge the status quo with digital treatments that improve cognition while bringing joy to patients.
We're honored to be among the list of amazing innovators recognized by @GalienFdn for their work to improve the lives of patients around the world.